Oruka Therapeutics: Chief medical officer Joana Goncalves sold 7,000 shares

What happened Joana Goncalves, chief medical officer, exercised options to acquire 3,500 shares at $6.84 for $23,940 and 3,500 shares at $7.80 for $27,300 (total cost $51,240). On the same day she sold 2,853 shares at a weighted price of $73.89 for $210,806; 1,847 shares at $74.69 for $137,957; 1,400 shares at $75.48 for $105,677; 700 shares at $76.67 for $53,666; and 200 shares at $77.71 for $15,542, for total sales of 7,000 shares and proceeds of $523,648 (all on Oct 15, 2026).

Key details

• Transaction date: Oct 15, 2026. Form filed on Oct 15, 2026; no late filing indicated in the provided data.
• Exercises reported: 3,500 shares at $6.84 ($23,940) and 3,500 shares at $7.80 ($27,300).
• Open-market sales reported: total 7,000 shares for $523,648, split as listed above with weighted average prices.
• Price notes: reported prices are weighted averages; sales occurred at prices ranging approximately $73.21–$77.74 across the reported groups (see footnotes F2–F6).
• 10b5-1 plan: the sales were effected pursuant to a Rule 10b5-1 trading plan entered Sep 19, 2025 (F1).
• Other derivative entries: the filing also lists two exercise/conversion entries reported as disposed at $0.00 (marked as derivative) (F7, F8 note vesting schedules).
• Shares owned after the transactions: not specified in the provided summary of the filing.

Why it may matter

• Options exercise: the filing shows options were exercised on Oct 15, 2026 and shares were sold the same day, consistent with a cashless exercise structure in this filing.
  A filing does not show why the insider traded or why the company acted.